Background illustration for clinical trials search

Paid Clinical Trials Shreveport

Discover 137 paid clinical trials in Shreveport, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Shreveport LA, Tyler TX, Jackson MS, Austin TX,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase 2, Recruiting

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Shreveport LA, Houston TX, San Antonio TX, Hastings NE,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase 2, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Shreveport LA, Tyler TX, Fort Worth TX, Jackson MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).

for
Ovarian Cancer Recurrent
Location: Shreveport LA, Fort Worth TX, Oklahoma City OK,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06843447

Phase 1, Phase 2, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Shreveport LA, Nashville TN, Indianapolis IN,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Shreveport LA, Tyler TX, West Monroe LA, Greenville TX,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Shreveport LA, Little Rock AR, Houston TX,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Shreveport LA, Richardson TX, Dallas TX, Arlington TX,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Phase 4, Recruiting

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

for
Pneumococcal Disease
Location: Shreveport LA, Plano TX, Oklahoma City OK,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07573462

Phase 3, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Shreveport LA, Lewisville TX, Lafayette LA,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase 3, Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Bossier City LA, Shreveport LA, Longview TX,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase 3, Recruiting

Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes

for
Penile Implantation, Infections
Location: Bossier City LA, Raleigh NC, Philadelphia PA
Sponsor: MicroGenDX

Sex: Male

Age: 18 - 70+

Code: NCT05287438

Recruiting

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

for
Prostate Cancer
Location: Bossier City LA, San Antonio TX, Woodbury MN,
Sponsor: Francis Medical Inc.

Sex: Male

Age: 0+

Code: NCT07455058

Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Shreveport LA, Dallas TX, Houston TX, Nashville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase 3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Shreveport LA, Dallas TX, Springdale AR, Birmingham AL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

for
Wide Neck Bifurcation Intracranial Aneurysms
Location: Shreveport LA, Memphis TN, Oklahoma City OK,
Sponsor: Microvention-Terumo, Inc.

Sex: All

Age: 18+

Code: NCT04839705

Recruiting

Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility

for
Normal and Diseased Tissue and Body Fluids Samples
Location: Shreveport LA, Fort Worth TX, Baton Rouge LA, Tulsa OK,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01354002

Recruiting

A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

for
Complicated Intra-abdominal Infections (cIAI)
Location: Shreveport LA, Chicago IL, Morgantown WV, Orange CA,
Sponsor: Tetraphase Pharmaceuticals, Inc

Sex: All

Age: 8 - 17

Code: NCT06794541

Phase 2, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Shreveport LA, Houston TX, Birmingham AL, Atlanta GA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06615479

Phase 3, Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: Shreveport LA, Dallas TX, San Antonio TX, Nashville TN,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase 1, Phase 2, Recruiting